These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25832020)

  • 1. Prediction of the stability of meropenem in intravenous mixtures.
    Takasu Y; Yoshida M; Tange M; Asahara K; Uchida T
    Chem Pharm Bull (Tokyo); 2015; 63(4):248-54. PubMed ID: 25832020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the stability of imipenem in intravenous mixtures.
    Yoshida M; Takasu Y; Shimizu K; Asahara K; Uchida T
    Chem Pharm Bull (Tokyo); 2013; 61(1):1-7. PubMed ID: 23124620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the stability of octreotide in a mixed infusion.
    Takasu Y; Yoshida M; Shimizu K; Asahara K; Tange M; Uchida T
    Chem Pharm Bull (Tokyo); 2014; 62(4):316-21. PubMed ID: 24695340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of meropenem in normal saline solution after storage at room temperature.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability prediction of nafamostat mesilate in an intravenous admixture containing sodium bisulfite.
    Asahara K; Yamada H; Yoshida S; Hirose S
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):492-7. PubMed ID: 2337964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.
    Franceschi L; Cojutti P; Baraldo M; Pea F
    Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of meropenem in a portable infusion device in a cold pouch.
    Grant EM; Zhong MK; Ambrose PG; Nicolau DP; Nightingale CH; Quintiliani R
    Am J Health Syst Pharm; 2000 May; 57(10):992-5. PubMed ID: 10832500
    [No Abstract]   [Full Text] [Related]  

  • 8. Stability of meropenem and doripenem solutions for administration by continuous infusion.
    Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM
    J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
    Bigley FP; Forsyth RJ; Henley MW
    Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic assay for meropenem in serum.
    Elkhaïli H; Niedergang S; Pompei D; Linger L; Leveque D; Jehl F
    J Chromatogr B Biomed Appl; 1996 Nov; 686(1):19-26. PubMed ID: 8953188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state.
    Cielecka-Piontek J; Zajac M; Jelińska A
    J Pharm Biomed Anal; 2008 Jan; 46(1):52-7. PubMed ID: 17936535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of human insulin in solutions containing sodium bisulfite.
    Asahara K; Yamada H; Yoshida S
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2662-6. PubMed ID: 1806287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution.
    Takeuchi Y; Sunagawa M; Isobe Y; Hamazume Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):689-92. PubMed ID: 7600618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
    Mendez AS; Dalomo J; Steppe M; Schapoval EE
    J Pharm Biomed Anal; 2006 Jun; 41(4):1363-6. PubMed ID: 16533586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of 2-hydropropyl-beta-cyclodextrin in the stabilization of frozen formulations.
    Wong J; Kipp JE; Miller RL; Nair LM; Ray GJ
    Eur J Pharm Sci; 2014 Oct; 62():281-92. PubMed ID: 24932711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of stability-indicating HPLC method for simultaneous determination of meropenem and potassium clavulanate.
    Zalewski P; Cielecka-Piontek J; Paczkowska M
    Acta Pol Pharm; 2014; 71(2):255-60. PubMed ID: 25272645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stability of a novel carbapenem antibiotic, meropenem (SM-7338), in a solid state formulation for injection.
    Takeuchi Y; Takebayashi Y; Sunagawa M; Isobe Y; Hamazume Y; Uemura A; Noguchi T
    Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1998-2002. PubMed ID: 8293523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiamine destruction by sodium bisulfite in infusion solutions.
    Scheiner JM; Araujo MM; DeRitter E
    Am J Hosp Pharm; 1981 Dec; 38(12):1911-3. PubMed ID: 7325171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal and alkaline stability of meropenem: degradation products and cytotoxicity.
    Mendez A; Chagastelles P; Palma E; Nardi N; Schapoval E
    Int J Pharm; 2008 Feb; 350(1-2):95-102. PubMed ID: 17904314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis.
    Teitelbaum AM; Meissner A; Harding RA; Wong CA; Aldrich CC; Remmel RP
    Bioorg Med Chem; 2013 Sep; 21(17):5605-17. PubMed ID: 23845282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.